Home/ Supplements/ Vitamin A/ OB Complete Premier

OB Complete Premier

product on market Tablet or Pill Vertical Pharmaceuticals Safety: 98/100
98/100

This product looks safe

  • Folate: 1667mg is 1667.0× the Tolerable Upper Intake Level (1.0mg)
  • 73% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile contains essential vitamins and minerals, including Vitamin D and Calcium, which have strong evidence for supporting bone health and immune function. Vitamin C and E provide antioxidant support based on moderate research. The formulation maintains a high safety score, indicating a low risk of adverse effects.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Folate: 1667mg is 1667.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for OB Complete Premier
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
30
Servings
Multi-Vitamin and Mineral (MVM)
Product Type
73%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
630 mcg RAE (48% DV)
Vitamin C
120 mg (100% DV)
Calcium
100 mg (8% DV)
20 mcg (133% DV)
1.3× RDA — within safe limits 608 studies (A:16, B:251)
13 mg (68% DV)
Within RDA (0.9× RDA) 179 studies (A:3, B:90)
2 mg (143% DV)
1.7× RDA — within safe limits 76 studies (A:0, B:33)
34 mg (213% DV)
26.2× RDA — above typical dose 13 studies (A:0, B:1)
10 mg NE (58% DV)
Within RDA (0.7× RDA) 196 studies (A:5, B:63)
10 mg (500% DV)
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
1667 mcg DFE (278% DV)
Exceeds UL by 1667.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
15 mcg (535% DV)
6.2× RDA — above typical dose 139 studies (A:1, B:44)
Iron
50 mg (185% DV)
15 mg (4% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
10 mg (77% DV)
Within RDA (0.9× RDA) 263 studies (A:6, B:134)
1 mg (77% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)

Other Ingredients

Microcrystalline Cellulose Dicalcium Phosphate Croscarmellose Sodium Hydroxypropylmethylcellulose Polyvinyl Alcohol Titanium Dioxide Polyethylene Glycol Talc FD&C Red #40 Lake fumed Silica Stearic Acid Magnesium Stearate Acacia Povidone K30
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Directions For Use One tablet daily or as directed by a physician.

One tablet daily

Warnings & Precautions

Adverse Reactions: Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein.

However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.

Keep this product out of reach of children.

For use on the order of a healthcare practitioner. Call your doctor about side effects. To report side effects, call Vertical Pharmaceuticals at 1-877-95-VERTI (1-877-958-3784) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Contraindications OB Complete Premier should not be used by patients with a known hypersensitivity to any of the listed ingredients.

Warnings Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Precautions Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin b12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

The patient's medical conditions and consumption of other drugs, herbs, and/or supplements should be considered. Drug Interactions OB Complete Premier tablets are not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g. Aspirin, Heparin, Clopidogrel).

Adverse Reactions: Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein.

However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.

Formulation Notes

Vegetarian friendly prenatal nutrition

Gluten free Sugar free Lactose free

Before, during, and after pregnancy

OB Complete Premier is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in postnatal period for both lactating and non-lactating mothers.

Gluten-, Lactose-, and sugar-free

Additional Information

Description OB Complete Premier is pink tablet, imprinted "VP043."

How Supplied OB Complete Premier is supplied in a carton of 30 tablets, packaged in 3 child resistant unit-dose blister cards of 10 tablets per card.

Storage: Store at controlled room temperature 15 degrees-30 degrees C (59 degrees-86 degrees F) [See USP]. Protect from light, moisture and excessive heat.

The confident choice

Metadata

Product Details

UPC / SKU3 68025 04330 4
DSLD Entry Date2021-12-18
Product TypeMulti-Vitamin and Mineral (MVM)
FormTablet or Pill
DSLD ID264194
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

View all Vitamin A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.